U.S. Paper and Forestry Products Stock News

In recent days, Ducommun has reported that strong defense demand, especially in missile programs, is helping counter ongoing commercial aviation weakness tied to Boeing’s inventory destocking. The company’s Vision 2027 plan, aiming for US$950–US$1.00 billion in revenue and 18% margins with help from acquisitions, highlights how management is leaning on deal-making alongside organic initiatives to reshape the business mix and financial profile. We’ll now examine how Ducommun’s defense-driven...

Equifax (EFX) recently reported Q4 2025 results that surpassed analyst expectations on both EPS and revenue, and that stronger quarter has coincided with a more positive stance from analysts on the stock. See our latest analysis for Equifax. The stronger Q4 report and launch of the new myEquifax consumer app have come after a tougher stretch for shareholders, with a 30 day share price return of 11.65% and a 90 day share price return of 14.78%. At the same time, the 1 year total shareholder...

In March 2026, PROCEPT BioRobotics announced that the European Association of Urology updated its guidelines to give Aquablation therapy a strong recommendation as a surgical option for men with benign prostatic hyperplasia, particularly those seeking to preserve ejaculatory function. This upgrade, grounded in a large body of randomized and long-term clinical evidence and aligned with support from bodies such as NICE in the UK, further embeds Aquablation within mainstream urologic practice...

Pomerantz LLP has launched an investigation into Weis Markets, Inc. after the retailer disclosed in the past that it would restate certain financial statements due to inaccurately recorded and overstated inventory, and delay filing its 2025 Annual Report while the review is completed. The combination of a restatement tied to inventory overstatement and an external securities-law investigation raises deeper questions about Weis Markets’ internal controls, governance, and financial reporting...

United States Antimony Corporation recently restarted mining operations at its Montana properties following a winter shutdown, introduced GPS-based vein mapping and mulch-based reclamation practices, and expanded its portfolio with new antimony-focused mining claims in Alaska, Montana, and Ontario. These operational changes and resource acquisitions could meaningfully influence how investors assess the company’s production potential, asset base, and long-term operating profile. We’ll now...

Surgery Partners (SGRY) is back in focus after reporting softer quarterly results, characterized by weak sales volumes, slower projected revenue growth, and high debt levels that increase financial risk and keep investor sentiment cautious. See our latest analysis for Surgery Partners. The share price slump has been sharp, with a 12.5% 30 day share price return and a 20.2% year to date share price return contributing to a 46.6% 1 year total shareholder return, which points to fading momentum...

On March 23, 2026, First Industrial Realty Trust, Inc. reported that activist investor Land & Buildings withdrew its director nominee ahead of the April 30, 2026 annual meeting, while the Board authorized a US$250 million share repurchase and announced the addition of new independent director Frank E. Schmitz effective June 1, 2026. This resolution of the proxy dispute, paired with a sizable buyback authorization, underscores management’s focus on governance stability and capital returns for...

In March 2026, AnaptysBio announced plans to spin off First Tracks Biotherapeutics, manage existing drug collaborations with GSK and Vanda, operate with limited staff and expenses, and start with about US$140 million to US$145 million in net cash and investments, while also launching a US$100 million share repurchase program and withdrawing a US$100 million at-the-market equity offering. The combination of a buyback authorization, canceled equity raise, and the addition of seasoned...

Recent performance snapshot Tractor Supply (TSCO) has drawn attention after a one-month return of about a 15% decline and a past three-month return of about a 14% decline, putting its recent performance in sharper focus for investors. See our latest analysis for Tractor Supply. The recent 30 day share price return of around a 15% decline and year to date share price return of about a 14% decline suggest momentum has been fading, even though the 5 year total shareholder return of roughly 35%...

Westlake (WLK) is back in focus after an earnings miss that contrasted with a wave of analyst upgrades, with sentiment supported by signs of polyethylene cycle acceleration and tighter supply from temporary global shutdowns. See our latest analysis for Westlake. That bullish backdrop has been reflected in the price action, with a 61.02% year to date share price return and a 30.13% 1 year total shareholder return. This suggests momentum has been building despite the recent earnings miss. If...

Fresh Del Monte Produce (FDP) is back on investors’ radar after reporting quarterly revenue of US$1.02b, flat year on year, while exceeding expectations on earnings and gross margin. This prompted a 3.7% post-earnings share price gain. See our latest analysis for Fresh Del Monte Produce. The earnings beat comes on top of a 16.8% 90 day share price return and a 35.7% 1 year total shareholder return. Together, these figures suggest improving sentiment after a softer recent 30 day share price...

Lucid Group (LCID) is back in focus after unveiling its updated 2027 Gravity SUV lineup. The company is pairing richer standard features and a new Prestige Package with recent commentary on margin goals and broader market reach. See our latest analysis for Lucid Group. The Gravity news lands at a time when Lucid’s 1 day share price return of 4.18% contrasts with a year to date share price return of negative 10.67% and a 1 year total shareholder return of negative 57.07%. This points to short...

In March 2026, large shareholders including OEP VII GP, L.L.C. and ONE EQUITY PARTNERS purchased nearly US$24.3 million of AdaptHealth common stock following its mixed Q4 2025 results, where earnings per share missed expectations but revenue slightly exceeded forecasts. The scale and timing of these insider and institutional purchases, occurring soon after the earnings release, suggest that key long-term holders viewed the post-result setup as attractive despite recent profitability...

Ocular Therapeutix (OCUL) is drawing fresh attention as investors look ahead to upcoming April conferences, where the company plans to share additional analyses from its pivotal Phase 3 SOL-1 trial of AXPAXLI. See our latest analysis for Ocular Therapeutix. At a share price of US$8.49, Ocular Therapeutix has seen a 1-day share price return of 1.92% and 7-day share price return of 5.20%. The 30-day share price return of 21.10% and year to date share price return of 28.17% are being considered...

Annaly Capital Management (NLY) drew fresh attention after investor Bill Ackman publicly called mortgage finance names “stupidly cheap” and outlined what he views as a highly skewed risk reward, sparking a 1.9% intraday share move. See our latest analysis for Annaly Capital Management. At a share price of $21.37, Annaly’s 1 day share price return of 1.14% and 7 day share price return of 1.47% sit against a 30 day share price return of a 7.25% decline. Its 1 year total shareholder return of...

In recent days, AppFolio’s shares have moved on growing attention to its upcoming earnings release, where analysts expect year-over-year increases in both earnings and revenue. This anticipation is reinforced by AppFolio’s current Zacks Rank of #2 (Buy), signaling relatively strong analyst confidence despite a premium valuation. With analysts projecting earnings of $1.44 per share for the upcoming report, we’ll examine how this shapes AppFolio’s broader investment narrative. Rare earth...

Marsh & McLennan Companies (MRSH) is back in focus after the firm promoted Ted Moynihan to president and CEO of Marsh Management Consulting and Oliver Wyman, continuing a broader reshuffle across its senior leadership. See our latest analysis for Marsh & McLennan Companies. The share price has softened recently, with a 30 day share price return of 5.22% and a year to date share price return decline of 4.31%. However, the 5 year total shareholder return of 50.16% points to a much stronger...

VEON Ltd. recently announced that its subsidiary JazzCash has onboarded its 1 millionth Raast QR-enabled merchant in Pakistan, extending what it calls the country’s largest digital payment acceptance network across corner shops, micro-entrepreneurs, retailers and online businesses. This milestone highlights how JazzCash, with 58 million registered customers and PKR 15,000,000 million (roughly US$53 billion) in 2025 transaction value, is becoming a core pillar of Pakistan’s push toward...

National Fuel Gas Company recently entered into an amended and restated US$1.30 billion unsecured revolving credit facility with a consortium of major banks, extending its maturity to March 27, 2031, and refining interest terms and financial covenants. This long-dated, covenant-linked credit line gives National Fuel Gas an additional tool to manage refinancing, working capital, and acquisition funding across its diversified energy operations. We’ll now examine how this extended US$1.30...

Why Tompkins Financial Stock Is Back on Investor Radar Tompkins Financial (TMP) is in focus after selling Tompkins Insurance Agencies, Inc. to Arthur J. Gallagher & Co., alongside Q3 2025 profit growth of 27% and a higher dividend. See our latest analysis for Tompkins Financial. The recent insurance sale, leadership transition plans at Tompkins Community Bank and partnership to expand digital banking all sit behind a gradual uptrend, with a 90 day share price return of 10.84% and a 1 year...

Legend Biotech stock reaction and recent performance context Legend Biotech (NasdaqGS:LEGN) has been drawing attention after recent price moves, with the stock up around 9% over the past week and roughly 7% over the past month, while showing weaker year to date and 1 year returns. Those mixed returns, including a 42% 1 year total return decline and a 63% 3 year total return decline, have investors reassessing how the current US$19.14 share price compares with the company’s latest...

In recent days, Allocate, a private markets infrastructure platform, announced a relationship with Valhalla Group, a private equity firm led by former Northern Trust executive Trey Hart, to integrate Allocate’s tools into Valhalla’s portfolio tracking and fundraising workflows. Separately, analyst research now reflects improving sentiment toward Northern Trust, with upgraded rankings and higher full-year earnings estimates pointing to a more optimistic view of its profit outlook. We’ll now...

In recent days, Bank of America upgraded Formula One Group, highlighting its durable and visible business model despite recent race cancellations in the Middle East. The bank also argued that Formula One’s live sports content is relatively insulated from AI-related disruption in media and entertainment, potentially reinforcing its role as a premium rights holder. We’ll now examine how this confidence in Formula One’s resilient business model and AI-resistant live sports content shapes its...

Earlier this year, Vera Bradley announced a limited-edition Mother’s Day collaboration with Bath & Body Works, featuring three exclusive fragrances, custom cosmetic bags, and 22 product forms across body care, home fragrance, decor, and accessories, with prices ranging from US$1.95 to US$69.95 and an international rollout to more than 40 markets. A distinctive aspect of the tie-up is the jointly developed Peach Blossom & Nectar scent and coordinated Vera Bradley designs, which align with...